PD Dr. Michael Erdmann

Department of Dermatology

Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics (2025) Cuba L, Dörje F, Kramer R, Dürr P, Erdmann M, Fromm M, Berking C, Geßner K Journal article Bowenoide Präkanzerose unter dem klinischen Bild eines einseitigen Lidekzems (2025) Zieringer L, Erdmann M Journal article Long-term follow-up of real-world adjuvant anti-PD1 checkpoint inhibition and targeted therapy in stage III melanoma patients (2025) Lodde GC, Hassel JC, von Wasielewski I, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells. (2025) Sauerer T, Bremm F, Beenen A, Heger L, Dudziak D, Bosch NC, Erdmann M, et al. Journal article Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care (2024) Heinlein L, Maron RC, Hekler A, Haggenmüller S, Wies C, Utikal JS, Meier F, et al. Journal article Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study (2024) Beckmann M, Schlüter J, Erdmann M, Kramer R, Cunningham S, Hackstein H, Zimmermann R, Heinzerling L Journal article Metastasiertes ekkrines Porokarzinom bei einem jungen Patienten (2024) Kramer R, Agaimy A, Berking C, Erdmann M Journal article Influence of the Immune Checkpoint Inhibitors on the Hemostatic Potential of Blood Plasma (2024) Patalakh I, Wandersee A, Schlüter J, Erdmann M, Hackstein H, Cunningham S Journal article, Original article Gleichzeitiges Auftreten zweier malignomverdächtiger Hautveränderungen (2024) Kaufmann M, Erdmann M, Schliep S, Voskens C, Berking C, Bauerschmitz J Journal article Dermatologist-like explainable AI enhances trust and confidence in diagnosing melanoma (2024) Brinker TJ, Chanda T, Hauser K, Hobelsberger S, Bucher TC, Garcia CN, Wies C, et al. Journal article